HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catharine R Cowan Selected Research

Phosphotransferases (Kinase)

2/2013Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catharine R Cowan Research Topics

Disease

3Neoplasms (Cancer)
02/2013 - 09/2010
1Adenocarcinoma
02/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2013
1Neoplasm Metastasis (Metastasis)
01/2012
1Disease Progression
01/2012
1Carcinoma (Carcinomatosis)
09/2010

Drug/Important Bio-Agent (IBA)

2GelsIBA
01/2012 - 09/2010
1trametinibIBA
02/2013
1Lapatinib (GW572016)FDA Link
02/2013
1ErbB Receptors (EGF Receptor)IBA
02/2013
1tyrosine receptor (receptor, tyrosine)IBA
02/2013
1Phosphotransferases (Kinase)IBA
02/2013
1Mitogen-Activated Protein KinasesIBA
02/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2013
1Proteins (Proteins, Gene)FDA Link
01/2012
1polyacrylamide gelsIBA
01/2012
1Biological ProductsIBA
09/2010
1Transcription Factors (Transcription Factor)IBA
09/2010
1Cadherins (E-Cadherin)IBA
09/2010

Therapy/Procedure

1Therapeutics
01/2012